(NASDAQ:LAB), SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that […]
(NASDAQ:CCBG), TALLAHASSEE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $16.0 million, or $0.93 per diluted share, for the third quarter of 2025 compared to $15.0 million, or $0.88 per diluted share, for the second quarter of 2025, and $13.1
Capital Square, a leading sponsor of tax-advantaged real estate investments and a national developer and manager of housing communities, today announced the launch of CS1031 The Villages at Miami Gardens BFR Housing, DST, a Delaware statutory trust that owns The Villages at Miami Gardens, a 50-unit build-for-rent townhome community in the Miami suburb of Miami
Agreement establishes industry-first persistent optical connectivity in orbit, ushering in a new era of real-time satellite operations Muon Space, a leading end‑to‑end space systems provider specializing in mission‑optimized satellite constellations, today announced an agreement with SpaceX's Starlink to integrate its mini laser terminals into Muon's high-performance Halo™ satellite platform. https://mma.prnewswire.com/media/2101252/Muon_Space_New_Logo.jpg Starlink's mini lasers are designed
Nasdaq Announces Quarterly Dividend of $0.27 Per Share GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common stock. The dividend is payable on December 19, 2025 to shareholders
Eightfold AI Appoints Navneet Singh as Chief Marketing Officer to Accelerate Global AI Adoption in Talent GlobeNewswire October 21, 2025 SANTA CLARA, Calif. , Oct. 21, 2025 (GLOBE NEWSWIRE) — Eightfold AI, the company redefining how the world hires, develops, and retains talent through responsible, enterprise-grade AI, today announced the appointment of Navneet Singh as
(NASDAQ:IMRN),(Other OTC:AFDG),(NYSE Arca:VGZ),(TSX:VGZ),(NYSE:CIA),(NasdaqGM:CRVO),(OTCQB:CYBHF),(TSX-V:CYBE),(OTCQB:COPAF),(TSX-V:CPAU),(OTCQB:WRLGF),(TSX-V:WRLG),(OTCQB:CUAUF),(TSX-V:CCCM),(Other OTC:BSAI),(PinkSheets:KBRIF),(TSX-V:KRI),(NYSE Arca:ATCH), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products &
Start-up company leverages AI innovations to advance cybersecurity for connected vehicles & supply chains VxLabs- Shielding Innovation and Securing Mobility – announces ThreatZ, a next-generation cybersecurity management and compliance platform that uses AI to help automotive security teams move with speed, efficiency, and consistency to protect connected, autonomous, and software-defined vehicles in a rapidly evolving
(NASDAQ:TNXP), CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), which was investigated as TNX-102 SL, will be presented by Dr. Gregory Sullivan, M.D., Chief Medical Officer of Tonix Pharmaceuticals,
(NASDAQ:IBIO), SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral presentation at ObesityWeek 2025 November 4-7 in Atlanta. In addition, Martin Brenner, DVM, Ph.D., Chief Executive Officer and